tiprankstipranks
BetterLife Pharma (BETRF)
OTHER OTC:BETRF

BetterLife Pharma (BETRF) Income Statement

24 Followers

BetterLife Pharma Income Statement

Last quarter (Q3 2024), BetterLife Pharma's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, BetterLife Pharma's net income was C$-195.46K. See BetterLife Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jan 23Jan 22Jan 21Jan 20Jan 19
Total Revenue
----C$ 0.00C$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 2.90MC$ 9.00M-C$ 24.28MC$ 9.20MC$ 6.52M
Operating Income
C$ -2.90MC$ -9.00M-C$ -24.28MC$ -9.20MC$ -6.52M
Net Non Operating Interest Income Expense
C$ -26.41KC$ -35.41K-C$ -188.98KC$ -424.30KC$ -1.08M
Other Income Expense
C$ -235.85KC$ 134.42K-C$ -205.74KC$ -9.97MC$ -1.65M
Pretax Income
C$ -2.78MC$ -9.37M-C$ -36.42MC$ -19.59MC$ -9.25M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -2.22MC$ -9.02M-C$ -36.42MC$ -19.59MC$ -9.25M
Basic EPS
C$ -0.02C$ -0.10-C$ -1.34C$ -1.30C$ -1.00
Diluted EPS
C$ -0.02C$ -0.10-C$ -1.34C$ -1.30C$ -1.00
Basic Average Shares
C$ 408.61MC$ 86.56M-C$ 27.03MC$ 15.04MC$ 9.02M
Diluted Average Shares
C$ 408.61MC$ 86.56M-C$ 27.03MC$ 15.04MC$ 9.02M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 347.44KC$ 155.05K
Total Expenses
C$ 2.90MC$ 9.00M-C$ -7.95MC$ 9.20MC$ 6.52M
Net Income From Continuing And Discontinued Operation
C$ -2.22MC$ -9.02M-C$ -36.42MC$ -19.59MC$ -9.25M
Normalized Income
C$ -2.05MC$ -6.89MC$ 6.58KC$ 1.21MC$ -9.57MC$ -7.64M
Interest Expense
----C$ 428.78KC$ 1.08M
EBIT
C$ -2.74MC$ -9.34MC$ -10.72MC$ -36.23MC$ -19.16MC$ -8.17M
EBITDA
C$ -2.74MC$ -9.32MC$ -10.70MC$ -35.89MC$ -17.75MC$ -7.04M
Currency in CAD

BetterLife Pharma Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis